Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anemia | 2 | 2018 | 789 | 0.85 | Why? |
| Echinococcosis, Hepatic | 1 | 2018 | 18 | 0.76 | Why? |
| Echinococcosis | 1 | 2018 | 40 | 0.74 | Why? |
| Vitamin A Deficiency | 1 | 2017 | 16 | 0.71 | Why? |
| Flavoring Agents | 1 | 2017 | 20 | 0.69 | Why? |
| Folic Acid Deficiency | 1 | 2017 | 22 | 0.69 | Why? |
| Thinness | 1 | 2018 | 99 | 0.68 | Why? |
| Anesthesia, Inhalation | 1 | 2017 | 49 | 0.68 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2018 | 114 | 0.64 | Why? |
| Vitamin B 12 Deficiency | 1 | 2017 | 57 | 0.64 | Why? |
| Altitude | 2 | 2018 | 311 | 0.63 | Why? |
| Vitamin A | 1 | 2017 | 188 | 0.61 | Why? |
| Child Nutrition Disorders | 1 | 2017 | 86 | 0.61 | Why? |
| Organ Specificity | 1 | 2020 | 1070 | 0.60 | Why? |
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2015 | 72 | 0.59 | Why? |
| Anemia, Iron-Deficiency | 1 | 2018 | 210 | 0.59 | Why? |
| Trace Elements | 1 | 2017 | 284 | 0.51 | Why? |
| Micronutrients | 1 | 2017 | 310 | 0.50 | Why? |
| Diet | 4 | 2018 | 2052 | 0.50 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 1510 | 0.47 | Why? |
| Overweight | 1 | 2018 | 916 | 0.45 | Why? |
| Enoxaparin | 3 | 2021 | 1064 | 0.39 | Why? |
| Anaphylaxis | 1 | 2018 | 940 | 0.37 | Why? |
| Rural Population | 2 | 2018 | 2408 | 0.36 | Why? |
| Vitamins | 1 | 2017 | 1208 | 0.35 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.34 | Why? |
| Malnutrition | 1 | 2017 | 932 | 0.34 | Why? |
| India | 6 | 2018 | 11875 | 0.29 | Why? |
| Electrocardiography | 4 | 2020 | 3957 | 0.29 | Why? |
| Hemorrhage | 3 | 2021 | 3013 | 0.29 | Why? |
| Anticoagulants | 5 | 2021 | 9563 | 0.29 | Why? |
| Energy Intake | 2 | 2018 | 323 | 0.28 | Why? |
| Myocardial Infarction | 2 | 2017 | 3361 | 0.24 | Why? |
| Thrombosis | 5 | 2021 | 7504 | 0.22 | Why? |
| Heart Rate | 2 | 2020 | 1527 | 0.22 | Why? |
| Prevalence | 6 | 2018 | 25773 | 0.21 | Why? |
| Factor Xa | 1 | 2020 | 113 | 0.21 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.20 | Why? |
| Catatonia | 1 | 2021 | 102 | 0.19 | Why? |
| Immunocompetence | 1 | 2020 | 280 | 0.19 | Why? |
| Partial Thromboplastin Time | 1 | 2020 | 436 | 0.19 | Why? |
| Dietary Sucrose | 1 | 2018 | 15 | 0.18 | Why? |
| Adaptive Immunity | 2 | 2020 | 2585 | 0.18 | Why? |
| Percutaneous Coronary Intervention | 1 | 2015 | 3646 | 0.18 | Why? |
| Vegetarians | 1 | 2017 | 17 | 0.17 | Why? |
| Dietary Fats | 1 | 2018 | 96 | 0.17 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.16 | Why? |
| Minerals | 1 | 2017 | 86 | 0.16 | Why? |
| Growth Disorders | 1 | 2017 | 91 | 0.16 | Why? |
| Iodine | 1 | 2018 | 116 | 0.16 | Why? |
| Arrhythmias, Cardiac | 2 | 2020 | 2510 | 0.16 | Why? |
| Epinephrine | 1 | 2018 | 323 | 0.16 | Why? |
| Time | 1 | 2018 | 631 | 0.15 | Why? |
| Electroconvulsive Therapy | 1 | 2021 | 326 | 0.15 | Why? |
| Child Mortality | 1 | 2017 | 163 | 0.15 | Why? |
| Factor Xa Inhibitors | 1 | 2020 | 490 | 0.15 | Why? |
| Socioeconomic Factors | 3 | 2018 | 8495 | 0.15 | Why? |
| Hirudins | 1 | 2015 | 75 | 0.14 | Why? |
| Infant Mortality | 1 | 2017 | 268 | 0.14 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.14 | Why? |
| Heparin | 2 | 2020 | 2600 | 0.14 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.13 | Why? |
| Cross-Sectional Studies | 5 | 2018 | 53120 | 0.12 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.12 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.12 | Why? |
| Fatal Outcome | 2 | 2020 | 3438 | 0.12 | Why? |
| Iron | 1 | 2018 | 619 | 0.12 | Why? |
| Intubation, Intratracheal | 2 | 2018 | 3962 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.11 | Why? |
| Antithrombins | 1 | 2015 | 353 | 0.11 | Why? |
| Child | 5 | 2018 | 70012 | 0.11 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2015 | 365 | 0.11 | Why? |
| Delayed Diagnosis | 1 | 2021 | 1529 | 0.11 | Why? |
| National Health Programs | 1 | 2017 | 807 | 0.11 | Why? |
| Female | 16 | 2021 | 380317 | 0.10 | Why? |
| New York City | 2 | 2021 | 7432 | 0.10 | Why? |
| Humans | 26 | 2021 | 930598 | 0.10 | Why? |
| Male | 15 | 2021 | 367725 | 0.10 | Why? |
| Double-Blind Method | 2 | 2020 | 5988 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.09 | Why? |
| Child, Preschool | 3 | 2017 | 36283 | 0.09 | Why? |
| Venous Thrombosis | 2 | 2021 | 2739 | 0.09 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Sex Distribution | 1 | 2015 | 2083 | 0.09 | Why? |
| Endoscopy | 1 | 2018 | 1564 | 0.08 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.08 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.08 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.08 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Atrial Fibrillation | 1 | 2020 | 2320 | 0.08 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.08 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 5002 | 0.07 | Why? |
| Venous Thromboembolism | 2 | 2021 | 4273 | 0.07 | Why? |
| Age Distribution | 1 | 2015 | 3567 | 0.07 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.07 | Why? |
| Recombinant Proteins | 1 | 2015 | 3786 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Peptide Fragments | 1 | 2015 | 2075 | 0.07 | Why? |
| Iran | 3 | 2021 | 5467 | 0.07 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Aged | 7 | 2021 | 215776 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.05 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.05 | Why? |
| Defensins | 1 | 2020 | 64 | 0.05 | Why? |
| Glycosaminoglycans | 1 | 2020 | 140 | 0.05 | Why? |
| Data Warehousing | 1 | 2020 | 116 | 0.05 | Why? |
| Health Behavior | 1 | 2018 | 4449 | 0.05 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2020 | 159 | 0.05 | Why? |
| Patient Advocacy | 1 | 2021 | 173 | 0.05 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.05 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.04 | Why? |
| Infant | 2 | 2017 | 30274 | 0.04 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.04 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Syndrome | 1 | 2021 | 1310 | 0.04 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Th17 Cells | 1 | 2020 | 657 | 0.04 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.04 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.04 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2020 | 698 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2021 | 2324 | 0.03 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Autophagy | 1 | 2020 | 960 | 0.03 | Why? |
| Respiration, Artificial | 1 | 2018 | 22116 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.03 | Why? |
| Infant, Premature | 1 | 2017 | 883 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2021 | 3776 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| United States | 2 | 2017 | 46150 | 0.03 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.03 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.03 | Why? |
| Anesthesia | 1 | 2021 | 1236 | 0.03 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Pediatrics | 1 | 2017 | 2969 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Spain | 1 | 2017 | 15545 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Gupta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(187)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(209)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_